Itaconate and its derivatives ameliorate autoimmunity by suppressing Th17 cells via regulating mitophagy
Open Access
- 22 January 2026
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Abstract
Itaconate (ITA) originates by decarboxylation of cis-aconitate catalyzed by the enzyme aconitate decarboxylase 1. It has immunomodulatory properties, but iKeywords
Funding Information
- National Natural Science Foundation of China (82001722)
- National Natural Science Foundation of China (32200739)
- National Natural Science Foundation of China (33270957)
This publication has 74 references indexed in Scilit:
- 4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disordersAnnals of Clinical and Translational Neurology, 2024
- 4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet’s Uveitis and Experimental Autoimmune UveitisInflammation, 2024
- Chemoproteomics, A Broad Avenue to Target DeconvolutionAdvanced Science, 2023
- Decoding the molecular interplay in the central dogma: An overview of mass spectrometry‐based methods to investigate protein‐metabolite interactionsProteomics, 2023
- pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to ExerciseCell, 2020
- The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancerJournal of Molecular Medicine, 2020
- Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communitiesCurrent Opinion in Chemical Biology, 2020
- Targeted and proteome-wide analysis of metabolite–protein interactionsCurrent Opinion in Chemical Biology, 2020
- Nrf2 signaling pathway: Pivotal roles in inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006